Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.
ClinicalTrials.gov study NCT02283827. IPD Sharing: Not stated. Countries: 0. Publications: 0.
OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SUR
ClinicalTrials.gov study NCT02571556. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (L
ClinicalTrials.gov study NCT02472366. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05845502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
ClinicalTrials.gov study NCT06116968. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label Controlled Trial: Effectiveness of Balneotherapy in Palmoplantar Psoriasis and Contact Dermatitis.
ClinicalTrials.gov study NCT06458868. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjec
ClinicalTrials.gov study NCT03010982. IPD Sharing: NO. Countries: 1. Publications: 0.
First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study
ClinicalTrials.gov study NCT06130722. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans
ClinicalTrials.gov study NCT02312492. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
ClinicalTrials.gov study NCT01635764. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI
ClinicalTrials.gov study NCT02018549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With TBR1-related Neurocognitive Disorder
ClinicalTrials.gov study NCT06776848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47
ClinicalTrials.gov study NCT02340208. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/
ClinicalTrials.gov study NCT07376642. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
ClinicalTrials.gov study NCT06975605. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Admini
ClinicalTrials.gov study NCT01853722. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.
ClinicalTrials.gov study NCT00407095. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Open Label Tolerability Study of ISOThrive Prebiotic Nectar (MIMO) in Subjects With Constipation
ClinicalTrials.gov study NCT04677634. IPD Sharing: NO. Countries: 1. Publications: 0.
Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trial
ClinicalTrials.gov study NCT01235221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients
ClinicalTrials.gov study NCT05089435. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.